An experimental vaccine against breast cancer
Dr. Amit Kumar discusses the partnership with the Cleveland Clinic to develop an experimental vaccine for breast cancer.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Amit Kumar, Ph.D., Chairman, President & Chief Executive Officer of Anixa Biosciences.
An experienced research scientist, executive, and investor, Dr. Amit Kumar is currently Chairman, President and Chief Executive Officer of Anixa Biosciences, and sits on the Board of Directors of the American Cancer Society.
Over the past 20 years, Dr. Kumar has performed and managed research programs in both cancer diagnostics and therapeutics and is credited as the inventor of Anixa’s Cchek™ technology. He has advised investment funds, venture capital firms and Fortune 500 companies and accrued extensive experience as a founder, director, and chief executive of several public and private technology enterprises.
Dr. Kumar served as Chief Executive Officer of CombiMatrix Corp. for a decade and worked with the venture capital firm Oak Investment Partners. From 2002 to 2008, he served on the Board of Directors of Acacia Research Corp. He joined the Board of Directors of the American Cancer Society in 2016, and also serves on the boards of several other public and private biotechnology companies.
He received his B.A. in chemistry from Occidental College and pursued graduate studies at Stanford University and the California Institute of Technology (Caltech). He earned a Ph.D. from Caltech and pursued a post-doctoral fellowship at Harvard University.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
